Ownership history in MATHER GROUP, LLC. · 4 quarters on record
This page tracks every 13F SEC filing in which MATHER GROUP, LLC. reported a position in BIOCRYST PHARMACEUTICALS INC (BCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 355 | — | 0% | 0.00% | $3K | $7.59 |
| 2025 Q1 | UNCHANGED | 355 | — | 0% | 0.00% | $3K | $7.50 |
| 2024 Q2 | ADDED | 355 | +155 | +77.5% | 0.00% | $2K | $6.18 |
| 2024 Q1 | INITIATED | 200 | — | — | 0.00% | $1K | — |
As of 2025 Q4 — sorted by position size